Publications

Operational lessons learned in conducting an international study on pharmacovigilance in pregnancy in resource-constrained settings: The WHO Global Vaccine safety Multi-Country collaboration project.

Sharan, A; Jahagirdar, S; Stuurman, AL; Elango, V; Riera-Montes, M; Kumar Kashyap, N; Kumar Arora, N; Mathai, M; MANGTANI, P; Devlieger, H; Anderson, S; Whitaker, B; Wong, H-L; Cutland, CL; Guillard Maure, C; WHO Global Vaccine Safety Multi-Country Collaborat,;

2022

VACCINE: X, (2022).11, 10.1016/j.jvacx.2022.100160.

Impact of seasonal RTS,S/AS01E vaccination plus seasonal malaria chemoprevention on the nutritional status of children in Burkina Faso and Mali.

GRANT, J; Sagara, I; Zongo, I; CAIRNS, M; Yerbanga, RS; Diarra, M; Zoungrana, C; Issiaka, D; Nikièma, F; Sompougdou, F; Tapily, A; Kaya, M; Haro, A; Sanogo, K; Sienou, AA; Traore, S; Thera, I; Yalcouye, H; Kuepfer, I; SNELL, P; MILLIGAN, P; Ockenhouse, C; Ofori-Anyinam, O; Tinto, H; Djimde, A; ... Ouédraogo, J-B.

2022

Malaria Journal, (2022).21 1 10.1186/s12936-022-04077-x.

TBVAX Model.

CLARK, R; MUKANDAVIRE, C; WEERASURIYA, C; Bakker, R; WHITE, RG;

2022

, Zenodo (2022).

Development of an educational package for the universal human papillomavirus (HPV) vaccination programme: a co-production study with young people and key informants.

Fisher, H; CHANTLER, T; Finn, A; Kesten, J; Hickman, M; Letley, L; MOUNIER-JACK, S; Thomas, C; Worthington, K; Yates, J; Audrey, S;

2022

Research involvement and engagement, (2022).8 1 10.1186/s40900-022-00349-7.

Effectiveness of a pay-it-forward intervention compared with user-paid vaccination to improve influenza vaccine uptake and community engagement among children and older adults in China: a quasi-experimental pragmatic trial.

WU, D; Jin, C; Bessame, K; Tang, FF-Y; Ong, JJ; Wang, Z; Xie, Y; JIT, M; LARSON, HJ; CHANTLER, T; LIN, L; Gong, W; Yang, F; Jing, F; Wei, S; Cheng, W; Zhou, Y; Ren, N; Qiu, S; Bao, J; Wen, L; Yang, Q; Tian, J; Tang, W; TUCKER, JD;

2022

The Lancet Infectious diseases, (2022).22 10 10.1016/S1473-3099(22)00346-2.

Evolving measles status and immunization policy development in six European countries.

Vojtek, I; LARSON, H; Plotkin, S; Van Damme, P;

2022

Human vaccines & immunotherapeutics, (2022).18 1 10.1080/21645515.2022.2031776.

Demonstrating multi-country calibration of a tuberculosis model using new history matching and emulation package - <i>hmer</i>.

Scarponi, D; Iskauskas, A; Clark, R; Vernon, I; McKinley, T; Goldstein, M; Mukandavire, C; Deol, A; WEERASURIYA, C; Bakker, R; WHITE, R; MCCREESH, N;

2022

medRxiv (2022). 10.1101/2022.05.13.22275052.

Updating age-specific contact structures to match evolving demography in a dynamic mathematical model of tuberculosis vaccination.

WEERASURIYA, CK; Harris, RC; MCQUAID, CF; Gomez, GB; WHITE, RG;

2022

PLoS Computational Biology, (2022).18 4 10.1371/journal.pcbi.1010002.

Tailoring immunisation programmes in a time of SARS-CoV-2: What can be learnt by comparing the findings of childhood and COVID-19 vaccine evaluation studies in an underserved population?.

KASSTAN, B; Letley, L; MOUNIER-JACK, S; Klynman, N; GASKELL, KM; EGGO, RM; MARKS, M; CHANTLER, T;

2022

Public health in practice, (2022).4, 10.1016/j.puhip.2022.100287.

WHO preferred product characteristics for monoclonal antibodies for passive immunization against respiratory syncytial virus (RSV) disease in infants - Key considerations for global use.

Sparrow, E; ADETIFA, I; Chaiyakunapruk, N; Cherian, T; Fell, DB; Graham, BS; Innis, B; Kaslow, DC; Karron, RA; Nair, H; Neuzil, KM; Saha, S; SMITH, PG; Srikantiah, P; Were, F; Zar, HJ; Feikin, D;

2022

Vaccine, (2022).40 26 10.1016/j.vaccine.2022.02.040.